The Cost of Pushing Pills

A new article in PLoS Medicine, "The Cost of Pushing Pills: A New Estimate of Pharmaceutical Promotion Expenditures in the United States," concludes that:


"...it appears that pharmaceutical companies spend almost twice as much on promotion as they do on R&D. These numbers clearly show how promotion predominates over R&D in the pharmaceutical industry, contrary to the industry's claim. ...(This) confirms the public image of a marketing-driven industry and provides an important argument to petition in favor of transforming the workings of the industry in the direction of more research and less promotion."

About this Entry

This page contains a single entry by Gary Schwitzer published on January 7, 2008 9:11 AM.

Online guides to candidates' health policy positions was the previous entry in this blog.

More journalistic screening bias: "a matter of faith not science" is the next entry in this blog.

Find recent content on the main index or look in the archives to find all content.

Archives

Pages

Wikio - Top of the Blogs - Health

Add to Technorati Favorites